Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2200]

Ideal checklist for clinical trial design and appraisal

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Ideal checklist for clinical trial design and appraisal ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Dr Sabita Jiwnani - Tata Memorial Hospital, Mumbai, India

Lung Cancer ( Dr Sabita Jiwnani - Tata Memorial Hospital, Mumbai, India )

Head and Neck Cancers

Dr Vijay Patil - Hinduja Hospital & Medical Research Centre, Mumbai

Head and Neck Cancers ( Dr Vijay Patil - Hinduja Hospital & Medical Research Centre, Mumbai )

Real world evidence research asking the right question

Dr Kumar Prabhash - Tata Memorial Hospital, Mumbai, India

Real world evidence research asking the right question ( Dr Kumar Prabhash - Tata Memorial Hospital, Mumbai, India )

Gordon McVie Lecture “Nag foundation": Delivering on outcomes that matter for...

Dr Shona Nag - Sahyadri Hospital, Pune, India

Gordon McVie Lecture “Nag foundation": Delivering on outcomes that matter for cancer patients ( Dr Shona Nag - Sahyadri Hospital, Pune, India )

Patient benefit vs industry benefit finding a balance

Dr Bishal Gyawali - Queen's University, Kingston, Canada

Patient benefit vs industry benefit finding a balance ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )

Balancing innovation and Common Sense In Oncology (CSO)

Prof Richard Sullivan - King's College London, UK

Balancing innovation and Common Sense In Oncology (CSO) ( Prof Richard Sullivan - King's College London, UK )

Common Sense in Oncology – Why

Dr Christopher Booth - Queen's University, Canada

Common Sense in Oncology – Why ( Dr Christopher Booth - Queen's University, Canada )

Integration of evidence-informed decision making into policymaking

Dr Meritxell Mallafré Larrosa - City Cancer Challenge, USA

Integration of evidence-informed decision making into policymaking ( Dr Meritxell Mallafré Larrosa - City Cancer Challenge, USA )

2 year recurrence free survival benefit for resectable melanoma treated with...

Dr Sapna Patel - MD Anderson Cancer Center, Houston, USA

2 year recurrence free survival benefit for resectable melanoma treated with neoadjuvant/adjuvant pembrolizumab ( Dr Sapna Patel - MD Anderson Cancer Center, Houston, USA )

Value of mentorship

Dr Ramila Shilpakar - National Academy Of Medical Sciences, Bir Hospital, Nepal

Value of mentorship ( Dr Ramila Shilpakar - National Academy Of Medical Sciences, Bir Hospital, Nepal )

Responding to reviewers

Prof David Collingridge - The Lancet Oncology, London, UK

Responding to reviewers ( Prof David Collingridge - The Lancet Oncology, London, UK )

More from ecancer